Ascend Wellness Holdings (AAWH) Change in Accured Expenses (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Change in Accured Expenses came in at $1.9 million in Q1 2026, up 124.36% year-on-year from $863794.3 in Q1 2025, and down 79.15% quarter-over-quarter from $9.3 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 124.36% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 202.16% increase from a year earlier, with the FY2025 full-year figure at $595000.0, up 134.88% from the prior year.
  • Change in Accured Expenses retreated to $1.9 million in Q1 2026 per AAWH's latest filing, from $9.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $14.2 million in Q4 2023 and bottomed at -$9.1 million in Q3 2025.
  • The 5-year median for Change in Accured Expenses is $605000.0 (2024), against an average of $1.7 million.
  • Biggest YoY gain for Change in Accured Expenses was 1792.09% in 2025; the steepest drop was 1415.04% in 2025.
  • Year by year, Change in Accured Expenses stood at -$8.0 million in 2022, then surged by 277.51% to $14.2 million in 2023, then slumped by 76.26% to $3.4 million in 2024, then jumped by 175.6% to $9.3 million in 2025, then plunged by 79.15% to $1.9 million in 2026.
  • Per Business Quant, the three latest AAWH Change in Accured Expenses figures stand at $1.9 million (Q1 2026), $9.3 million (Q4 2025), and -$9.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 90.13 Bn 88.27 Bn - -
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn -
5 United Therapeutics 23.08 Bn 20.93 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.38 Bn 18.57 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.80 Bn 16.48 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn -
10 Ascend Wellness Holdings 77.94 Mn 17.02 Mn 44.88 Mn 1.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.94 Mn
Mar 31, 2026 1.94 Mn
Dec 31, 2025 9.30 Mn
Dec 31, 2025 9.30 Mn
Sep 30, 2025 -9.09 Mn
Sep 30, 2025 -9.09 Mn
Jun 30, 2025 8.34 Mn
Jun 30, 2025 8.34 Mn
Mar 31, 2025 -7.96 Mn
Mar 31, 2025 -7.96 Mn
Dec 31, 2024 3.37 Mn
Dec 31, 2024 3.37 Mn
Sep 30, 2024 -5.19 Mn
Sep 30, 2024 -5.19 Mn
Jun 30, 2024 -493,000.00
Jun 30, 2024 -493,000.00
Mar 31, 2024 605,000.00
Mar 31, 2024 605,000.00
Dec 31, 2023 14.21 Mn
Dec 31, 2023 14.21 Mn